These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 9316075)

  • 1. Technetium-99m-labeled receptor-specific small-molecule radiopharmaceuticals: recent developments and encouraging results.
    Hom RK; Katzenellenbogen JA
    Nucl Med Biol; 1997 Aug; 24(6):485-98. PubMed ID: 9316075
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacological effects of dopaminergic drugs on in vivo binding of [99mTc]TRODAT-1 to the central dopamine transporters in rats.
    Dresel SH; Kung MP; Plössl K; Meegalla SK; Kung HF
    Eur J Nucl Med; 1998 Jan; 25(1):31-9. PubMed ID: 9396872
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tc-99m-labeled tropanes as dopamine transporter imaging agents.
    Meegalla S; Plössl K; Kung MP; Chumpradit S; Stevenson DA; Frederick D; Kung HF
    Bioconjug Chem; 1996; 7(4):421-9. PubMed ID: 8853455
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vivo imaging of serotonin transporters with [99mTc]TRODAT-1 in nonhuman primates.
    Dresel SH; Kung MP; Huang X; Plössl K; Hou C; Shiue CY; Karp J; Kung HF
    Eur J Nucl Med; 1999 Apr; 26(4):342-7. PubMed ID: 10199939
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Specificity of diastereomers of [99mTc]TRODAT-1 as dopamine transporter imaging agents.
    Meegalla SK; Plössl K; Kung MP; Stevenson DA; Mu M; Kushner S; Liable-Sands LM; Rheingold AL; Kung HF
    J Med Chem; 1998 Feb; 41(4):428-36. PubMed ID: 9484494
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [99mTc]TRODAT-1: a novel technetium-99m complex as a dopamine transporter imaging agent.
    Kung MP; Stevenson DA; Plössl K; Meegalla SK; Beckwith A; Essman WD; Mu M; Lucki I; Kung HF
    Eur J Nucl Med; 1997 Apr; 24(4):372-80. PubMed ID: 9096087
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Simultaneous SPECT studies of pre- and postsynaptic dopamine binding sites in baboons.
    Dresel SH; Kung MP; Huang XF; Plössl K; Hou C; Meegalla SK; Patselas G; Mu M; Saffer JR; Kung HF
    J Nucl Med; 1999 Apr; 40(4):660-6. PubMed ID: 10210226
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Technepine: a high-affinity 99m-technetium probe to label the dopamine transporter in brain by SPECT imaging.
    Madras BK; Jones AG; Mahmood A; Zimmerman RE; Garada B; Holman BL; Davison A; Blundell P; Meltzer PC
    Synapse; 1996 Mar; 22(3):239-46. PubMed ID: 9132992
    [No Abstract]   [Full Text] [Related]  

  • 9. Radiopharmaceuticals for single-photon emission computed tomography brain imaging.
    Kung HF; Kung MP; Choi SR
    Semin Nucl Med; 2003 Jan; 33(1):2-13. PubMed ID: 12605353
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Biodistribution and dosimetry of TRODAT-1: a technetium-99m tropane for imaging dopamine transporters.
    Mozley PD; Stubbs JB; Plössl K; Dresel SH; Barraclough ED; Alavi A; Araujo LI; Kung HF
    J Nucl Med; 1998 Dec; 39(12):2069-76. PubMed ID: 9867143
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synthesis and characterization of technetium-99m-labeled tropanes as dopamine transporter-imaging agents.
    Meegalla SK; Plössl K; Kung MP; Chumpradit S; Stevenson DA; Kushner SA; McElgin WT; Mozley PD; Kung HF
    J Med Chem; 1997 Jan; 40(1):9-17. PubMed ID: 9016323
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Imaging of dopamine transporters in humans with technetium-99m TRODAT-1.
    Kung HF; Kim HJ; Kung MP; Meegalla SK; Plössl K; Lee HK
    Eur J Nucl Med; 1996 Nov; 23(11):1527-30. PubMed ID: 8854853
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Structure-activity relationships at the monoamine transporters and sigma receptors for a novel series of 9-[3-(cis-3, 5-dimethyl-1-piperazinyl)propyl]carbazole (rimcazole) analogues.
    Husbands SM; Izenwasser S; Kopajtic T; Bowen WD; Vilner BJ; Katz JL; Newman AH
    J Med Chem; 1999 Oct; 42(21):4446-55. PubMed ID: 10543888
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 99mTc-labeled small-molecule inhibitors of prostate-specific membrane antigen for molecular imaging of prostate cancer.
    Hillier SM; Maresca KP; Lu G; Merkin RD; Marquis JC; Zimmerman CN; Eckelman WC; Joyal JL; Babich JW
    J Nucl Med; 2013 Aug; 54(8):1369-76. PubMed ID: 23733925
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A technetium-99m SPECT imaging agent which targets the dopamine transporter in primate brain.
    Meltzer PC; Blundell P; Jones AG; Mahmood A; Garada B; Zimmerman RE; Davison A; Holman BL; Madras BK
    J Med Chem; 1997 Jun; 40(12):1835-44. PubMed ID: 9191960
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Recent advances in 99mTc radiopharmaceuticals.
    Arano Y
    Ann Nucl Med; 2002 Apr; 16(2):79-93. PubMed ID: 12043913
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Imaging of dopamine transporters in humans with technetium-99m TRODAT-1.
    Meltzer PC; Madras BK
    Eur J Nucl Med; 1997 Apr; 24(4):462-3. PubMed ID: 9198580
    [No Abstract]   [Full Text] [Related]  

  • 18. More advantages in detecting bone and soft tissue metastases from prostate cancer using
    Pianou NK; Stavrou PZ; Vlontzou E; Rondogianni P; Exarhos DN; Datseris IE
    Hell J Nucl Med; 2019; 22(1):6-9. PubMed ID: 30843003
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Greater availability of brain dopamine transporters in major depression shown by [99m Tc]TRODAT-1 SPECT imaging.
    Brunswick DJ; Amsterdam JD; Mozley PD; Newberg A
    Am J Psychiatry; 2003 Oct; 160(10):1836-41. PubMed ID: 14514499
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development of technetium-99m-based CNS receptor ligands: have there been any advances?
    Johannsen B; Pietzsch HJ
    Eur J Nucl Med Mol Imaging; 2002 Feb; 29(2):263-75. PubMed ID: 11926389
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.